Timeline of FDA approvals for the treatment of AML. CRi, complete remission with incomplete count recovery; dx, diagnosed; FDA, Food and Drug Administration; IC, intensive chemotherapy; LDAC, low dose cytarabine; MDS, myelodysplasia; Mut, mutated; R/R, relapsed and refractory.